U.S. PHARMACOPEIA

Search USP29  
Chlorthalidone
Click to View Image
C14H11ClN2O4S 338.77

Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-.
2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide [77-36-1].
» Chlorthalidone contains not less than 98.0 percent and not more than 102.0 percent of C14H11ClN2O4S, calculated on the dried basis.
Packaging and storage— Preserve in well-closed containers.
Identification—
B: Ultraviolet Absorption 197U
Solution: 100 µg per mL.
Medium: 2 N hydrochloric acid in methanol (1 in 50).
Absorptivities at 275 nm, calculated on the dried basis, do not differ by more than 4.0%.
C: Dissolve about 50 mg in 3 mL of sulfuric acid: an intense yellow color develops.
Loss on drying 731 Dry about 2 g, accurately weighed, at 105 for 4 hours: it loses not more than 0.4% of its weight.
Residue on ignition 281: not more than 0.1%.
Chloride 221 Shake 1.0 g with 40 mL of water for 5 minutes, and filter through chloride-free filter paper previously rinsed with water: the filtrate shows no more chloride than corresponds to 0.50 mL of 0.020 N hydrochloric acid (0.035%).
Heavy metals, Method II 231: 0.001%.
Limit of 4¢-chloro-3¢-sulfamoyl-2-benzophenone carboxylic acid (CCA)— Proceed as directed in the Assay, except to calculate the quantity, in mg, of CCA in the portion of Chlorthalidone taken by the formula:
(0.5)C(RU / RS),
in which C is the concentration, in µg per mL, of USP 4¢-Chloro-3¢-sulfamoyl-2-benzophenone Carboxylic Acid RS in the Standard preparation; and RU and RS are the peak response ratios of CCA and the internal standard obtained from the Assay preparation and the Standard preparation, respectively: not more than 1.0% is present.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a suitable degassed mixture of 0.01 M dibasic ammonium phosphate and methanol (3:2), adjust dropwise with phosphoric acid to a pH of 5.5 ± 0.1, and filter.
Internal standard solution— Prepare a solution of 2,7-naphthalenediol in methanol having a concentration of about 1.0 mg per mL.
CCA solution— Prepare a solution of USP 4¢-Chloro-3¢-sulfamoyl-2-benzophenone Carboxylic Acid RS in methanol having a known concentration of about 5 µg per mL.
Standard preparation— Prepare a solution of USP Chlorthalidone RS in methanol having a known concentration of about 1 mg per mL. Pipet 5 mL of this solution into a 50-mL volumetric flask containing 5.0 mL of Internal standard solution and 10.0 mL of CCA solution. Dilute with water to volume, and mix.
Assay preparation— Transfer about 50 mg of Chlorthalidone, accurately weighed, to a 50-mL volumetric flask, dissolve in and dilute with methanol to volume, and mix. Pipet 5 mL of this solution into a 50-mL volumetric flask containing 5.0 mL of Internal standard solution and 10.0 mL of methanol. Dilute with water to volume, and mix.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L7. The flow rate is about 1.0 mL per minute. Chromatograph five replicate injections of the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation is not more than 2.0%, and the resolution factors between Chlorthalidone and CCA, and between chlorthalidone and the internal standard, are not less than 1.5. The tailing factors for the Chlorthalidone and CCA peaks are not more than 2.0.
Procedure— Separately inject equal volumes (about 25 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 0.5 for CCA, 0.8 for Chlorthalidone and 1.0 for the internal standard. Calculate the quantity, in mg, of C14H11ClN2O4S in the portion of Chlorthalidone taken by the formula:
500C(RU / RS),
in which C is the concentration, in mg per mL, of USP Chlorthalidone RS in the Standard preparation; and RU and RS are the peak response ratios of chlorthalidone and the internal standard obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (MDCV05) Monograph Development-Cardiovascular
USP29–NF24 Page 499
Phone Number : 1-301-816-8305